SEARCH

SEARCH BY CITATION

References

  • 1
    Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. British Journal of Obstetrics and Gynaecology 2011; 118: 1203.
  • 2
    Lewis G (ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer – 2003–2005. The Seventh report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.
  • 3
    Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. European Society of Cardiology Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal 2011; 32: 314797.
  • 4
    Healthcare Improvement Scotland. Scottish Confidential Audit of Severe Maternal Morbidity, 7th Annual Report. Edinburgh, 2011. http://www.healthcareimprovementscotland.org/programmes/reproductive,_maternal__child/programme_resources/scasmm.aspx (accessed 30/12/2011).
  • 5
    Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. World Health Organization (WHO) analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 106674.
  • 6
    Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Review Cardiovascular Therapy 2007; 5: 28394.
  • 7
    McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. American Heart Journal 2008; 156: 91830.
  • 8
    Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115: 1481501.
  • 9
    Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the american heart association. Circulation 2011; 123: 124362.
  • 10
    Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797803.
  • 11
    Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. British Medical Journal 2003; 326: 845.
  • 12
    American College of Obstetrcians and Gynecologists practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. International Journal of Gynaecology and Obstetrics 2002; 77: 6775.
  • 13
    Chesley LC. Diagnosis of preeclampsia. Obstetrics and Gynecology 1985; 65: 4235.
  • 14
    Geller SE, Ahmed S, Brown ML, Cox SM, Rosenberg D, Kilpatrick SJ. International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it? American Journal of Obstetrics and Gynecology 2004; 190: 162933.
  • 15
    The Royal College of Obstetricians and Gynaecologists. The management of severe pre-eclampsia/eclampsia guideline number 10(A), 2006:111. http://www.rcog.org.uk/womens-health/clinical-guidance/management-severe-pre-eclampsiaeclampsia-green-top-10a accessed 30/12/2011.
  • 16
    Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? British Journal of Obstetrics and Gynaecology 2004; 111: 298302.
  • 17
    Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology 1986; 155: 5019.
  • 18
    Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Australian and New Zealand Journal of Obstetrics and Gynaecology 2009; 49: 2426. http://www.somanz.org/pdfs/somanz_guidelines_2008.pdf accessed 30/12/2011.
  • 19
    Rowe T. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology Canada. 2008; 30(Suppl): 148.
  • 20
    National Collaborating Centre for Women’s and Children’s Health. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence Guideline 107. August 2010 revised reprint January 2011 ed. London: RCOG, 2011. http://www.nice.org.uk/nicemedia/live/13098/50475/50475.pdf accessed 30/12/2011.
  • 21
    Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 14261.
  • 22
    Leanos-Miranda A, Marquez-Acosta J, Romero-Arauz F, et al. Protein:creatinine ratio in random urine samples is a reliable marker of increased 24-h protein excretion in hospitalized women with hypertensive disorders of pregnancy. Clinical Chemistry 2007; 53: 16238.
  • 23
    Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clinical Chemistry 2005; 51: 157786.
  • 24
    Cote AM, Brown M, Halstead C, von Daelszen P, Liston RM, Magee LA. Should the urinary spot protein/creatinine ratio (PCR) be used as a diagnostic test in hypertensive pregnant women:a systematic review. Hypertension in Pregnancy 2004; 23: 36.
  • 25
    Cnossen JS, de Ruyter-Hanhijarvi H, van der Post JA, Mol BW, Khan KS, ter Riet G. Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstetricia et Gynecologica Scandinavica 2006; 85: 51925.
  • 26
    Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57: 9516.
  • 27
    Bacq Y. Liver diseases unique to pregnancy: a 2010 update. Clinical Research Hepatology Gastroenterology 2011; 35: 18293.
  • 28
    Williams J, Mozurkewich E, Chilimigras J, Van De Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Practice Research and Clinical Obstetrics and Gynaecology 2008; 22: 82546.
  • 29
    Broekhuizen FF, Elejalde R, Hamilton PR. Early-onset preeclampsia, triploidy and fetal hydrops. Journal of Reproductive Medicine 1983; 28: 2236.
  • 30
    Dyer RA, Piercy JL, Reed AR. The role of the anaesthetist in the management of the pre-eclamptic patient. Current Opinion in Anesthesiology 2007; 20: 16874.
  • 31
    Plaat F, Wray S. Role of the anaesthetist in obstetric critical care. Best Practice Research and Clinical Obstetrics and Gynaecology 2008; 22: 91735.
  • 32
    Guise JM, Segel S. Teamwork in obstetric critical care. Best Practice Research and Clinical Obstetrics and Gynaecology 2008; 22: 93751.
  • 33
    Thornton C, Hennessy A, von Dadelszen P, Nishi C, Makris A, Ogle R. An international benchmarking collaboration: measuring outcomes for the hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology Canada 2007; 29: 794800.
  • 34
    Thornton CE, von Dadelszen P, Makris A, Tooher JM, Ogle RF, Hennessy A. Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertension in Pregnancy 2011; 30: 16979.
  • 35
    Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstetrics and Gynecology 2005; 105: 24654.
  • 36
    Hennessy A, Thornton CE, Makris A, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. Australia and New Zealand Journal of Obstetrics and Gynaecology 2007; 47: 27985.
  • 37
    Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007; 1: CD002252.
  • 38
    Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008; 51: 9609.
  • 39
    Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006; 3: CD001449.
  • 40
    Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. British Medical Journal 2003; 327: 95560.
  • 41
    Knight M. Eclampsia in the United Kingdom 2005. British Journal of Obstetrics and Gynaecology 2007; 114: 10728.
  • 42
    Duley L, Gülmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews 2010;9: CD002960.
  • 43
    Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2010;11: CD000025.
  • 44
    The Collaborative Eclampsia Trial Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 145563.
  • 45
    Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews 2010; 10: CD000128.
  • 46
    Duley L, Henderson-Smart DJ, Walker GJA, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews 2010; 12: CD000127.
  • 47
    Alexander JM, McIntire DD, Leveno KJ, Cunningham FG. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstetrics and Gynecology 2006; 108: 82632.
  • 48
    Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. American Journal of Obstetrics and Gynecology 1991; 164: 15009.
  • 49
    Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database of Systematic Reviews 2010; 9: CD008148.
  • 50
    O’Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. American Journal of Obstetrics and Gynecology 2002; 186: 4759.
  • 51
    Katz L, de Amorim MM, Figueiroa JN, Pinto e Silva JL. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. American Journal of Obstetrics and Gynecology 2008; 198: 283. e1-8.
  • 52
    The Royal College of Obstetricians and Gynaecologists. Blood transfusion in obstetrics. Guideline Number 47. 2007:110. http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT47BloodTransfusions1207amended.pdf accessed 30/12/2011.
  • 53
    Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database of Systematic Reviews 1999; 4: CD001805.
  • 54
    Ganzevoort W, Rep A, Bonsel GJ, et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. British Journal of Obstetrics and Gynaecology 2005; 112: 135868.
  • 55
    Sriram S, Robertson MS. Critically ill obstetric patients in Australia: a retrospective audit of 8 years’ experience in a tertiary intensive care unit. Critical Care and Resuscitation 2008; 10: 124.
  • 56
    Dunne C, Meriano A. Acute postpartum pulmonary edema in a 23-year-old woman 5 days after cesarean delivery. Canadian Journal of Emergency Medicine 2009; 11: 17881.
  • 57
    Sibai BM, Mabie BC, Harvey CJ, Gonzalez AR. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. American Journal of Obstetrics and Gynecology 1987; 156: 11749.
  • 58
    Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990–1999. Anesthesiology 2004; 101: 9509.
  • 59
    Lucas MJ, Sharma SK, McIntire DD, et al. A randomized trial of labor analgesia in women with pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 2001; 185: 9705.
  • 60
    Newsome LR, Bramwell RS, Curling PE. Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia. Anesthesia and Analgesia 1986; 65: 316.
  • 61
    Visalyaputra S, Rodanant O, Somboonviboon W, Tantivitayatan K, Thienthong S, Saengchote W. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesthesia and Analgesia 2005; 101: 8628.
  • 62
    Sharma SK, Philip J, Whitten CW, Padakandla UB, Landers DF. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999; 90: 38590.
  • 63
    Dyer RA, Piercy JL, Reed AR, Lombard CJ, Schoeman LK, James MF. Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology 2008; 108: 80211.
  • 64
    Orlikowski CE, Rocke DA, Murray WB, et al. Thrombelastography changes in pre-eclampsia and eclampsia. British Journal of Anaesthesia 1996; 77: 15761.
  • 65
    Moore TR, Key TC, Reisner LS, Resnik R. Evaluation of the use of continuous lumbar epidural anesthesia for hypertensive pregnant women in labor. American Journal of Obstetrics and Gynecology 1985; 152: 40412.
  • 66
    Head BB, Owen J, Vincent RD Jr, Shih G, Chestnut DH, Hauth JC. A randomized trial of intrapartum analgesia in women with severe preeclampsia. Obstetrics and Gynecology 2002; 99: 4527.
  • 67
    Berends N, Teunkens A, Vandermeersch E, Van de Velde M. A randomized trial comparing low-dose combined spinal-epidural anesthesia and conventional epidural anesthesia for cesarean section in severe preeclampsia. Acta Anaesthesiologica Belgica 2005; 56: 15562.
  • 68
    Hadzic A, Vloka J, Patel N, Birnbach D. Hypertensive crisis after a successful placement of an epidural anesthetic in a hypertensive parturient. Case report. Regional Anesthesia 1995; 20: 1568.
  • 69
    Dyer RA, Els I, Farbas J, Torr GJ, Schoeman LK, James MF. Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace. Anesthesiology 2003; 99: 5619. discussion 5A-6A.
  • 70
    Wallace DH, Leveno KJ, Cunningham FG, Giesecke AH, Shearer VE, Sidawi JE. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstetrics and Gynecology 1995; 86: 1939.
  • 71
    Slogoff S, Keats AS, Arlund C. On the safety of radial artery cannulation. Anesthesiology 1983; 59: 427.
  • 72
    Frezza EE, Mezghebe H. Indications and complications of arterial catheter use in surgical or medical intensive care units: analysis of 4932 patients. American Journal of Surgery 1998; 64: 12731.
  • 73
    Mandel MA, Dauchot PJ. Radial artery cannulation in 1000 patients: precautions and complications. Journal of Hand Surgery 1977; 2: 4825.
  • 74
    Dyer RA, Piercy JL, Reed AR, Lombard CJ, Schoeman LK, James MF. Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology 2008; 108: 80211.
  • 75
    Langesaeter E. Is it more informative to focus on cardiac output than blood pressure during spinal anesthesia for cesarean delivery in women with severe preeclampsia? Anesthesiology 2008; 108: 7712.
  • 76
    Douglas PS, Garcia MJ, Haines DE, et al. Appropriate use criteria for echocardiography. Journal of the American Society of Echocardiography 2011; 24: 22967.
  • 77
    Dennis AT. Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness. International Journal of Obstetric Anesthesia 2011; 20: 1608.
  • 78
    Salem R, Vallee F, Rusca M, Mebazaa A. Hemodynamic monitoring by echocardiography in the ICU: the role of the new echo techniques. Current Opinion in Critical Care 2008; 14: 5618.
  • 79
    Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011; 57: 8593.
  • 80
    Dennis AT. Cardiac function in women with preeclampsia. PhD Thesis, Department of Pharmacology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne. http://repository.unimelb.edu.au/10187/9005 (accessed 30/12/2011).
  • 81
    Dennis A, Castro J, Simmons S, Carr C, Permezel M, Royse C. Left ventricular systolic and diastolic function and structure in women with untreated preeclampsia. International Journal of Obstetric Anesthesia 2010; 19: S154.
  • 82
    Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. Journal of Hypertension 2009; 27: 225764.
  • 83
    The Maternal Critical Care Working Group. Providing equity of critical and maternity care for the critically ill pregnant or recently pregnant woman: Royal College of Anaesthetists, 2011 http://www.rcoa.ac.uk/docs/Prov_Eq_Mat_and_CritCare.pdf (accessed 30/12/2011).
  • 84
    Macintyre PE, Schug SA, Scott DA, Visser EJ, Walker SM, Acute Pain Management: Scientific Evidence Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence, 3rd edn. Melbourne: Australian and New Zealand College of Anaesthetists and the Faculty of Pain Medicine, 2010.
  • 85
    Makris A, Thornton C, Hennessy A. Postpartum hypertension and nonsteroidal analgesia. American Journal of Obstetrics and Gynecology 2004; 190: 5778.
  • 86
    Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstetrics and Gynecology 2006; 108: 8338.
  • 87
    Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN Jr. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstetrics and Gynecology 2003; 101: 669.
  • 88
    Norwitz ER, Hsu CD, Repke JT. Acute complications of preeclampsia. Clinical Obstetrics and Gynecology 2002; 45: 30829.
  • 89
    Dennis AT, Solnordal CB. Acute pulmonary oedema in pregnant women. Anaesthesia 2012; 67: 64659.
  • 90
    Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH. Acute pulmonary edema in pregnancy. Obstetrics and Gynecology 2003; 101: 5115.
  • 91
    Barton JR, Sibai BM. Acute life-threatening emergencies in preeclampsia – eclampsia. Clinical Obstetrics and Gynecology 1992; 35: 40213.
  • 92
    Steyn DW, Steyn P. Low-dose dopamine for women with severe pre-eclampsia. Cochrane Database of Systematic Reviews 2007; 1: CD003515.
  • 93
    Magee L, Sadeghi S, vonDadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database of Systematic Reviews 2005; 1: CD004351.
  • 94
    Idama TO, Lindow SW. Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. British Journal of Obstetrics and Gynaecology 1998; 105: 2608.
  • 95
    Iffy L, McArdle JJ, Ganesh V, Hopp L. Bromocriptine related atypical vascular accidents postpartum identified through medicolegal reviews. Medical Law 1996; 15: 12734.